Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2024 Earnings Call Transcript March 18, 2025
Eton Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.02 EPS, expectations were $-0.02.
Operator: Good day, and thank you for standing by. Welcome to the Eton Pharmaceuticals, Inc. Investor Day and Fourth Quarter 2024 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today’s conference is being recorded....
